Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers

NCT00319748 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Ovarian Cancer
Endometrial Cancer
Cervical Cancer

Interventions

DRUG: 852A

Sponsor

Masonic Cancer Center, University of Minnesota

Collaborators

[object Object]